Dati del progetto

• IATI IDXM-DAC-6-4-012350-01-1
• Inizio previsto 31/03/2022
• Fine prevista 31/12/2022
• Inizio effettivo 17/06/2022
• Fine effettiva 13/02/2023
• Bi/Multilaterale Bilateral
• Stato Chiuso
• Tied status Slegato

Settori

• 12250 - Controllo delle malattie infettive 100.0%

Policy marker

• Uguaglianza di Genere Non pertinente
• Disaster Risk Reduction (DRR) Non pertinente
• Nutrition Non pertinente
• Aiuto all’Ambiente Non pertinente
• Sviluppo partecipativo e buon governo Non pertinente
• Sviluppo del Commercio Non pertinente
• Biodiversità Non pertinente
• Cambiamenti Climatici Mitigazione Non pertinente
• Cambiamenti Climatici Adattamento Non pertinente
• Desertificazione Non pertinente

Obiettivi

• 17.16 - Enhance the Global Partnership for Sustainable Development, complemented by multi-stakeholder partnerships that mobilize and share knowledge, expertise, technology and financial resources, to support the achievement of the Sustainable Development Goals in all countries, in particular developing countries
• 17.17 - Encourage and promote effective public, public-private and civil society partnerships, building on the experience and resourcing strategies of partnerships
• 3.3 - By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases
• 3.8 - Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all
• 3.b - Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
• 3.d - Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks